Lawrence Steinman, MD

Professor of Neurology and Neurological Sciences, Pediatrics, and Genetics; and head, Steinman Lab, Stanford Medicine


Future Direction of MS Treatment

June 10, 2021

Key opinion leaders in neurology, Lawrence Steinman, MD and Enrique Alvarez, MD, PhD, reflect on future developments in the management of multiple sclerosis and share key advice for community physicians.

Ublituximab for MS: The ULTIMATE I and II Trials

June 03, 2021

Experts in the management of multiple sclerosis provide key insights into the use of ublituximab in multiple sclerosis and review results of the ULTIMATE I and II trials from the AAN 2021 Annual Meeting.  

Monitoring Response and Sequencing Therapies in RRMS

June 03, 2021

Enrique Alvarez, MD, PhD reviews factors to consider when monitoring response to treatment, and Lawrence Steinman, MD comments on patient- and disease-related factors that may impact therapeutic sequencing.